Page 8 - 33Emerging Trends in MRI and CT Scan
P. 8

researchers and clinicians can identify imaging-genomic associations that provide insights into

               disease  subtypes,  prognosis,  and  potential  therapeutic  targets.  This  integration  contributes  to
               personalized medicine approaches, where treatment decisions are guided by both imaging and

               genomic information. g. Multimodal Imaging Integration: Combining MRI with other imaging
               modalities, such as positron emission tomography (PET) or CT scan, further enhances diagnostic

               accuracy and treatment planning. Multimodal imaging provides complementary information about

               anatomical,  functional,  and  molecular  characteristics  of  tissues,  enabling  a  comprehensive
               assessment of disease. It facilitates the integration of different imaging biomarkers and enables a

               more holistic approach to precision medicine. Conclusion: Advancements in MRI technology have
               significantly enhanced diagnostic imaging capabilities and paved the way for precision medicine

               approaches.  The  improved  image  quality,  functional  and  molecular  imaging  techniques,  AI

               integration, and the ability to extract quantitative imaging biomarkers have revolutionized the field
               of diagnostic imaging. MRI plays a critical role in personalized diagnosis, treatment planning,

               therapeutic response monitoring, and treatment guidance. In the era of precision medicine, MRI
               provides clinicians with valuable tools to tailor medical interventions based on individual patient

               characteristics. The  integration  of  genomic  data,  multimodal  imaging,  and AI-driven  analysis
               further expands the potential of MRI in precision medicine. As technology continues to advance,

               MRI is expected to play an increasingly vital role in delivering personalized and targeted care to

               patients, ultimately improving outcomes and transforming the practice of medicine.

                   References



                   1.  Kalor, A., Girometti, R., Maheshwari, E., Kierans, A. S., Pugliesi, R. A., Buros, C., &
                       Furlan, A. (2022). Update on MR Contrast Agents for Liver Imaging: What to Use and

                       When. Radiologic Clinics, 60(5), 679-694.

                   2.  Pugliesi, A. R., Kersjes, W., Degenkolb, J., & Aoua, D. O. (2020, January). Many names
                       of dementia. European Congress of Radiology-ECR 2020.

                   3.  Pugliesi, A. R., Kersjes, W., Degenkolb, J., Vögele, M. I., Meixel, A., & Hesse, M. A.
                       (2019,  January).  Hodgkin  and  non-Hodgkin  Lymphoma.  The  Radiological  approach.

                       European Congress of Radiology-ECR 2019.
                   4.  Bailey,  R.  E.,  Pugliesi,  R. A.,  Borja—Cacho,  D.,  &  Borhani, A. A.  (2023).  Imaging

                       Evaluation of the Living Liver Donor: A Systems-Based Approach. Radiologic Clinics.
   3   4   5   6   7   8   9